Results 211 to 220 of about 159,425 (263)
As use cases for long‐acting therapeutics expand across clinical indications, there is a critical need to ensure the inclusion of women who are pregnant or breastfeeding, infants and children—populations with a historical gap in the availability of interventions already approved for use in adults.
Moherndran Archary +59 more
wiley +1 more source
Long‐Acting Therapeutics in Pediatric Health: Bridging Innovation and Access
Children have distinct therapeutic needs arising from age‐dependent physiology, disease epidemiology, formulation requirements, dosing considerations, and safety vulnerabilities. Despite substantial reductions in childhood mortality over the past three decades, nearly 5 million children under five died in 2023, with infectious diseases continuing to ...
Prajith Venkatasubramanian +5 more
wiley +1 more source
Siltartoxatug, a first‐in‐class monoclonal antibody targeting tetanus toxin for post‐exposure prophylaxis, was evaluated in two phase I trials in Australian and Chinese healthy adults. In these randomized, double‐blind, placebo‐controlled, dose‐escalation studies, participants received a single intramuscular injection of siltartoxatug (10–250 μg/kg) or
Xinyu Liu +15 more
wiley +1 more source
Diagnostic Lag in Precision Medicine
Clinical Pharmacology &Therapeutics, EarlyView.
Petr Heneberg
wiley +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Acta Clinica Belgica, 1994
For a long time it has been known that bacteraemias caused by medical or dental procedures may cause endocarditis in patients with specific types of congenital or acquired heart disease. In the 1940s it was thought that the administration of antibiotics before such procedures would prevent endocarditis. However, the beneficial effect of this preventive
openaire +5 more sources
For a long time it has been known that bacteraemias caused by medical or dental procedures may cause endocarditis in patients with specific types of congenital or acquired heart disease. In the 1940s it was thought that the administration of antibiotics before such procedures would prevent endocarditis. However, the beneficial effect of this preventive
openaire +5 more sources
Prophylaxis of Endophthalmitis
Ophthalmic Surgery, Lasers and Imaging Retina, 1994ABSTRACT Prophylactic antibiotics can be administered by various routes to prevent endophthalmitis. Topical application is simple and minimally invasive, but it provides relatively poor penetration into the vitreous. Collagen shields are effective in delivering therapeutic levels of antibiotics to the cornea and aqueous but not to the ...
G A, Peyman, M, Daun
openaire +2 more sources
Prophylaxis or No Prophylaxis before Transesophageal Echocardiography?
Journal of the American Society of Echocardiography, 1992The rationale for prevention of endocarditis is obvious. Infective endocarditis is a serious disease that carries with it significant mortality and morbidity. Even though the etiologic organisms can be effectively treated with appropriate antimicrobial therapy, the disease often leaves behind an unwelcome legacy of valvular destruction, resulting in ...
openaire +2 more sources
JAMA: The Journal of the American Medical Association, 1965
To the Editor:— As the number of aging persons in our population increases, diverticulosis and diverticulitis can be expected to become a more widespread medical problem. It is estimated that 5% to 10% of those over 40 have diverticulosis, and the percentage increases with age.
openaire +2 more sources
To the Editor:— As the number of aging persons in our population increases, diverticulosis and diverticulitis can be expected to become a more widespread medical problem. It is estimated that 5% to 10% of those over 40 have diverticulosis, and the percentage increases with age.
openaire +2 more sources

